Home › Companies › CATALYST PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 21, 2024: 10 items on CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed May 21, 2024: 10 without a stated outcome.
Meeting of August 22, 2023: 10 items on CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed August 25, 2023: 10 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore CATALYST PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are CATALYST PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. CATALYST PHARMACEUTICALS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Richard J. Daly | 88,161,224 | 1,489,928 | 193,687 | -- | 11,817,471 | 98% | Not verified | — |
| Elect Director: Patrick J. McEnany | 86,093,354 | 3,561,412 | 190,073 | -- | 11,817,471 | 96% | Not verified | — |
| Elect Director: Donald A. Denkhaus | 85,937,799 | 3,717,631 | 189,409 | -- | 11,817,471 | 96% | Not verified | — |
| Elect Director: Molly Harper | 86,018,457 | 3,637,844 | 188,538 | -- | 11,817,471 | 96% | Not verified | — |
| Elect Director: Charles B. O'Keeffe | 84,926,089 | 4,730,350 | 188,400 | -- | 11,817,471 | 95% | Not verified | — |
| Elect Director: Tamar Thompson | 85,049,382 | 4,604,945 | 190,512 | -- | 11,817,471 | 95% | Not verified | — |
| Elect Director: David S. Tierney | 85,767,244 | 3,885,606 | 191,989 | -- | 11,817,471 | 96% | Not verified | — |
| 2. Approval of an amendment to our 2018 Stock Incentive Plan | 86,817,240 | 2,859,403 | 168,196 | -- | 11,817,471 | 97% | Not verified | — |
| 3. Approval, on an advisory basis, of the 2023 compensation of our named executive officers | 84,194,484 | 5,468,681 | 181,674 | -- | 11,817,471 | 94% | Not verified | — |
| 4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 99,551,894 | 2,031,301 | 79,115 | -- | -- | 98% | Not verified | — |
Source: CATALYST PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Patrick J. McEnany | 74,672,480 | 1,183,192 | 102,149 | -- | 12,395,336 | 98% | Not verified | — |
| Elect Director: Richard J. Daly | 75,023,592 | 828,218 | 106,011 | -- | 12,395,336 | 99% | Not verified | — |
| Elect Director: Donald A. Denkhaus | 74,450,695 | 1,229,833 | 277,293 | -- | 12,395,336 | 98% | Not verified | — |
| Elect Director: Molly Harper | 74,886,349 | 795,997 | 275,475 | -- | 12,395,336 | 99% | Not verified | — |
| Elect Director: Charles B. O'Keeffe | 74,257,213 | 1,421,102 | 279,506 | -- | 12,395,336 | 98% | Not verified | — |
| Elect Director: Tamar Thompson | 75,486,875 | 193,861 | 277,085 | -- | 12,395,336 | 99.7% | Not verified | — |
| Elect Director: David S. Tierney | 60,628,318 | 15,052,826 | 276,677 | -- | 12,395,336 | 80% | Not verified | — |
| 2. Approval of an amendment to our 2018 Stock Incentive Plan | 73,160,219 | 2,659,621 | 137,981 | -- | 12,395,336 | 96% | Not verified | — |
| 3. Approval, on an advisory basis, of 2022 compensation of our named executive officers | 72,610,991 | 2,909,780 | 437,050 | -- | 12,395,336 | 96% | Not verified | — |
| 4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 | 87,621,416 | 277,620 | 454,121 | -- | -- | 99.6% | Not verified | — |
Source: CATALYST PHARMACEUTICALS INC., Form 8-K, filed with the SEC on August 25, 2023 — read the filing on EDGAR.
Each item below shows how the 333 asset managers that disclosed a CATALYST PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CATALYST PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held May 21, 2024.
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Charles B. O'Keeffe”): 84,926,089 for, 4,730,350 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,914,658 | 2,335 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 43,068,653 for, 37,502 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Donald A. Denkhaus as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Donald A. Denkhaus”): 85,937,799 for, 3,717,631 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 43,070,623 for, 35,532 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Molly Harper as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Molly Harper”): 86,018,457 for, 3,637,844 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 43,070,623 for, 35,532 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Patrick J. McEnany as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick J. McEnany”): 86,093,354 for, 3,561,412 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,407 | 1,586 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 42,984,937 for, 111,294 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Richard J. Daly as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Richard J. Daly”): 88,161,224 for, 1,489,928 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,407 | 1,586 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 43,083,019 for, 23,136 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect Tamar Thompson as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 85,049,382 for, 4,604,945 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 42,821,939 for, 284,216 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held May 21, 2024.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David S. Tierney”): 85,767,244 for, 3,885,606 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of CATALYST PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ELECT DIRECTOR DAVID S. TIERNEY” (2 managers, 9,924 for, 86,986 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,914,658 | 2,335 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 92 managers: 42,971,743 for, 37,502 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Charles B. O'Keeffe”): 74,257,213 for, 1,421,102 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,755,270 for, 28,368 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David S. Tierney”): 60,628,318 for, 15,052,826 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 28,304,464 for, 10,479,174 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 71,307 | 7,370,019 | 0 | 0 | Against |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 0 | 2,092,020 | 0 | 0 | Against |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 239,217 | 24,729 | 0 | 0 | Mixed |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Donald A. Denkhaus as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Donald A. Denkhaus”): 74,450,695 for, 1,229,833 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect Molly Harper as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Molly Harper”): 74,886,349 for, 795,997 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect Patrick J. McEnany as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick J. McEnany”): 74,672,480 for, 1,183,192 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,679,298 for, 104,340 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect Richard J. Daly as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Richard J. Daly”): 75,023,592 for, 828,218 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,755,520 for, 28,118 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held August 22, 2023.
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect Tamar Thompson as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 75,486,875 for, 193,861 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,768,378 for, 15,260 against, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Meeting held May 21, 2024.
Combines 2 wordings of this item as funds reported it.
2% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 12,056,213 | 0 | 0 | Against |
| Vanguard | 0 | 7,681,821 | 0 | 0 | Against |
| State Street | 5,393 | 5,911,600 | 0 | 0 | Against |
| Fidelity | 0 | 2,606,331 | 0 | 0 | Against |
| Dimensional | 0 | 2,312,134 | 0 | 0 | Against |
| Royce | 0 | 1,467,476 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,016,458 | 0 | 0 | Against |
| T. Rowe Price | 0 | 911,552 | 0 | 0 | Against |
| Invesco | 0 | 865,133 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 0 | 672,701 | 0 | 0 | Against |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 0 | 458,400 | 0 | 0 | Against |
| TIAA | 0 | 426,573 | 0 | 0 | Against |
| Janus Detroit Street Trust | 0 | 330,359 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 311,886 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 306,731 | 0 | 0 | Against |
| Northern Trust | 0 | 297,820 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 290,561 | 0 | 0 | Against |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 0 | 276,446 | 0 | 0 | Against |
| Jackson National | 0 | 267,975 | 0 | 0 | Against |
| First Trust | 0 | 223,487 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 195,270 | 0 | 0 | Against |
| BNY Mellon | 0 | 178,485 | 0 | 0 | Against |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 169,495 | 0 | 0 | Against |
Fund voting reports, all 91 managers: 305,605 for, 42,602,842 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 5 wordings of this item as funds reported it.
0% of fund votes cast · no official result
The 66 asset managers below reported 36,006,903 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 9,142,804 | 0 | 0 | Against |
| State Street | 0 | 7,441,326 | 0 | 0 | Against |
| Vanguard | 0 | 6,611,178 | 0 | 0 | Against |
| Dimensional | 0 | 2,092,020 | 0 | 0 | Against |
| Fidelity | 0 | 1,951,374 | 0 | 0 | Against |
| Invesco | 0 | 1,101,996 | 0 | 0 | Against |
| T. Rowe Price | 0 | 813,918 | 0 | 0 | Against |
| American Century | 0 | 745,781 | 0 | 0 | Against |
| Royce | 0 | 740,385 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 435,872 | 0 | 0 | Against |
| Northern Trust | 0 | 368,585 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| Equitable | 0 | 269,890 | 0 | 0 | Against |
| TIAA | 0 | 259,204 | 0 | 0 | Against |
| Allspring | 0 | 256,552 | 0 | 0 | Against |
| Janus Detroit Street Trust | 0 | 244,270 | 0 | 0 | Against |
| Voya | 0 | 236,211 | 0 | 0 | Against |
| Goldman Sachs | 0 | 205,437 | 0 | 0 | Against |
| BNY Mellon | 0 | 202,143 | 0 | 0 | Against |
| AllianceBernstein | 0 | 186,030 | 0 | 0 | Against |
| OBERWEIS FUNDS | 0 | 183,400 | 0 | 0 | Against |
| Victory Capital | 0 | 165,407 | 0 | 0 | Against |
| First Trust | 0 | 164,343 | 0 | 0 | Against |
| Brighthouse | 0 | 155,419 | 0 | 0 | Against |
| ProShares | 0 | 147,764 | 0 | 0 | Against |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Meeting held August 22, 2023.
13% of fund votes cast · no official result
The 27 asset managers below reported 348,195 for, 2,340,532 against, 23,783 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 0 | 858,074 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Jackson National | 0 | 263,946 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 239,839 | 0 | 0 | Against |
| SEI | 0 | 178,664 | 0 | 0 | Against |
| World Funds Trust | 0 | 154,809 | 0 | 0 | Against |
| Russell Investments | 0 | 123,192 | 0 | 0 | Against |
| Federated Hermes | 0 | 93,445 | 0 | 0 | Against |
| ADVISORS' INNER CIRCLE FUND | 0 | 74,900 | 0 | 0 | Against |
| EntrepreneurShares Series Trust | 0 | 73,805 | 0 | 0 | Against |
| Allianz | 0 | 71,107 | 0 | 0 | Against |
| CITY NATIONAL ROCHDALE FUNDS | 0 | 51,899 | 0 | 0 | Against |
| John Hancock | 0 | 37,701 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 24,505 | 0 | 0 | Against |
| Brighthouse | 0 | 0 | 23,783 | 0 | Abstain |
| Managed Portfolio Series | 0 | 22,901 | 0 | 0 | Against |
| Lincoln Financial | 16,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 16,849 | 0 | 0 | Against |
| Putnam | 0 | 14,779 | 0 | 0 | Against |
| NEW COVENANT FUNDS | 0 | 11,416 | 0 | 0 | Against |
| GPS Funds I | 0 | 10,835 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST II | 0 | 7,431 | 0 | 0 | Against |
| Pacer Funds Trust | 0 | 5,373 | 0 | 0 | Against |
| WILSHIRE MUTUAL FUNDS INC | 0 | 3,300 | 0 | 0 | Against |
| SYNTAX ETF TRUST | 0 | 1,762 | 0 | 0 | Against |
Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL TWO - To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“2. Approval of an amendment to our 2018 Stock Incentive Plan”): 73,160,219 for, 2,659,621 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 0 | 745,781 | 0 | 0 | Against |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Fund voting reports, all 90 managers: 37,953,220 for, 828,370 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| CORNELL UNIVERSITY | 1,939 | 0 | 0 | 0 | For |
| PEDDOCK CAPITAL ADVISORS, LLC | 900 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 109 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 2,948 for, 563,392 unknown.
Meeting held May 21, 2024.
98% of fund votes cast · no official result
Description as filed by funds: Election of Directors To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
The 66 asset managers below reported 39,700,114 for, 615,644 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,916,194 | 799 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 204,965 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
| Goldman Sachs | 141,147 | 0 | 0 | 0 | For |
| Principal | 127,499 | 0 | 0 | 0 | For |
| Victory Capital | 121,317 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Meeting held May 21, 2024.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“2. Approval of an amendment to our 2018 Stock Incentive Plan”): 86,817,240 for, 2,859,403 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Jackson National | 243,246 | 0 | 0 | 0 | For |
| Russell Investments | 117,897 | 0 | 0 | 0 | For |
| Prudential/PGIM | 115,519 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 90,000 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 85,596 | 0 | 0 | 0 | For |
| SEI | 83,196 | 0 | 0 | 0 | For |
| TANAKA FUNDS INC | 81,098 | 0 | 0 | 0 | For |
| Allianz | 66,677 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 60,985 | 0 | 0 | 0 | For |
| EntrepreneurShares Series Trust | 59,577 | 0 | 0 | 0 | For |
| Federated Hermes | 53,505 | 0 | 0 | 0 | For |
| Global X | 45,183 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 41,692 | 0 | 0 | 0 | For |
| John Hancock | 37,569 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 30,211 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 29,227 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,704 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,769 | 0 | 0 | 0 | For |
| Putnam | 0 | 14,111 | 0 | 0 | Against |
| Tema ETF Trust | 11,352 | 0 | 0 | 0 | For |
| GPS Funds I | 10,217 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 9,924 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 6,810 | 0 | 0 | 0 | For |
Fund voting reports, all 30 managers: 2,627,009 for, 14,111 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 500,200 for, 413,392 unknown.
Meeting held May 21, 2024.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the 2023 compensation of our named executive officers.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of the 2023 compensation of our named executive officers”): 84,194,484 for, 5,468,681 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,915,456 | 1,537 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 0 | 597,439 | 0 | 0 | Against |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 306,731 | 0 | 0 | Against |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 267,975 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 93 managers: 42,039,178 for, 1,066,977 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 7,922,822 | 2,274 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,045,754 | 0 | 0 | 0 | For |
| BlackRock | 3,760,560 | 15,065 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,507,305 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 2,485,040 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 1,457,090 | 0 | 0 | Against |
| T. Rowe Price | 1,197,635 | 0 | 0 | 0 | For |
| Northern Trust | 1,145,070 | 0 | 0 | 0 | For |
| Charles Schwab | 1,074,762 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,046,858 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 0 | 1,035,000 | 0 | 0 | Against |
| KENNEDY CAPITAL MANAGEMENT LLC | 942,872 | 5,929 | 0 | 0 | For |
| Invesco | 936,639 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 878,860 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 669,983 | 54 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 647,298 | 0 | 0 | 0 | For |
| Mesirow Institutional Investment Management, Inc. | 619,620 | 0 | 0 | 0 | For |
| American Century | 0 | 598,280 | 0 | 0 | Against |
| Renaissance | 525,697 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 448,025 | 21,900 | 0 | 0 | For |
| OBERWEIS ASSET MANAGEMENT INC/ | 458,400 | 0 | 0 | 0 | For |
| JPMorgan | 435,015 | 0 | 0 | 0 | For |
| Nuveen | 430,526 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 227 managers: 37,341,819 for, 6,496,052 against, 14 not voted, 413,392 unknown. Showing the 25 largest; see all in the interactive database.
Meeting held August 22, 2023.
Combines 12 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL THREE - To approve, on an advisory basis, the 2022 compensation of our named executive officers.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory basis, of 2022 compensation of our named executive officers”): 72,610,991 for, 2,909,780 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,101,996 | 0 | 0 | Against |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 356,094 | 0 | 0 | Against |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Fund voting reports, all 90 managers: 37,315,897 for, 1,465,693 against, 23,783 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 9,171,345 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,192,000 | 0 | 0 | 0 | For |
| BlackRock | 2,817,660 | 1,374 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,926,415 | 0 | 0 | 0 | For |
| Man Group plc | 1,313,460 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,150,019 | 0 | 0 | Against |
| T. Rowe Price | 1,088,082 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,016,746 | 0 | 0 | 0 | For |
| Maryland State Retirement & Pension System | 1,000,000 | 0 | 0 | 0 | For |
| Charles Schwab | 863,309 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 811,990 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Prudential/PGIM | 582,789 | 9,300 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 584,312 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 580,990 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 545,116 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 524,816 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 435,872 | 0 | 0 | 0 | For |
| Allspring | 353,410 | 0 | 0 | 0 | For |
| Voya | 298,526 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 291,401 | 5,100 | 0 | 0 | For |
| Putnam | 295,760 | 0 | 0 | 0 | For |
| AllianceBernstein | 292,660 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 281,998 | 0 | 0 | 0 | For |
Institutional-manager reports, all 201 managers: 40,579,340 for, 1,693,698 against, 563,392 unknown. Showing the 25 largest; see all in the interactive database.
Meeting held May 21, 2024.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 99,551,894 for, 2,031,301 against, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,056,213 | 0 | 0 | 0 | For |
| Vanguard | 7,681,821 | 0 | 0 | 0 | For |
| State Street | 5,916,194 | 799 | 0 | 0 | For |
| Fidelity | 2,606,331 | 0 | 0 | 0 | For |
| Dimensional | 2,312,134 | 0 | 0 | 0 | For |
| Royce | 1,467,476 | 0 | 0 | 0 | For |
| Charles Schwab | 1,016,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 911,552 | 0 | 0 | 0 | For |
| Invesco | 865,133 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 672,701 | 0 | 0 | 0 | For |
| American Century | 597,439 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 458,400 | 0 | 0 | 0 | For |
| TIAA | 426,573 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 330,359 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 311,886 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 306,731 | 0 | 0 | 0 | For |
| Northern Trust | 297,820 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 290,561 | 0 | 0 | 0 | For |
| JPMorgan | 285,125 | 0 | 0 | 0 | For |
| Equitable | 276,446 | 0 | 0 | 0 | For |
| Jackson National | 243,246 | 0 | 0 | 0 | For |
| First Trust | 223,487 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 195,270 | 0 | 0 | 0 | For |
| BNY Mellon | 178,485 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 169,495 | 0 | 0 | 0 | For |
Fund voting reports, all 91 managers: 42,956,079 for, 799 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 500,200 for.
Meeting held August 22, 2023.
Combines 8 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: PROPOSAL FOUR - To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
CATALYST PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023”): 87,621,416 for, 277,620 against, per its Form 8-K filed August 25, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 38,783,638 for, 23,783 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,142,804 | 0 | 0 | 0 | For |
| State Street | 7,441,326 | 0 | 0 | 0 | For |
| Vanguard | 6,611,178 | 0 | 0 | 0 | For |
| Dimensional | 2,092,020 | 0 | 0 | 0 | For |
| Fidelity | 1,951,374 | 0 | 0 | 0 | For |
| Invesco | 1,101,996 | 0 | 0 | 0 | For |
| Charles Schwab | 858,074 | 0 | 0 | 0 | For |
| T. Rowe Price | 813,918 | 0 | 0 | 0 | For |
| American Century | 745,781 | 0 | 0 | 0 | For |
| Royce | 740,385 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 435,872 | 0 | 0 | 0 | For |
| Northern Trust | 368,585 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 356,094 | 0 | 0 | 0 | For |
| JPMorgan | 330,971 | 0 | 0 | 0 | For |
| Equitable | 269,890 | 0 | 0 | 0 | For |
| Jackson National | 263,946 | 0 | 0 | 0 | For |
| TIAA | 259,204 | 0 | 0 | 0 | For |
| Allspring | 256,552 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 244,270 | 0 | 0 | 0 | For |
| Prudential/PGIM | 239,839 | 0 | 0 | 0 | For |
| Voya | 236,211 | 0 | 0 | 0 | For |
| Goldman Sachs | 205,437 | 0 | 0 | 0 | For |
| BNY Mellon | 202,143 | 0 | 0 | 0 | For |
| AllianceBernstein | 186,030 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 183,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 118,029,526 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 10.21% |
| 2 | Vanguard | 6.51% |
| 3 | State Street | 5.01% |
| 4 | Fidelity | 2.21% |
| 5 | Dimensional | 1.96% |
| 6 | Royce | 1.24% |
| 7 | Charles Schwab | 0.86% |
| 8 | T. Rowe Price | 0.77% |
| 9 | Invesco | 0.73% |
| 10 | JANUS INVESTMENT FUND | 0.57% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 6.71% |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.43% |
| 3 | BlackRock | 3.20% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.12% |
| 5 | Man Group plc | 2.11% |
| 6 | MARSHALL WACE, LLP | 1.23% |
| 7 | T. Rowe Price | 1.01% |
| 8 | Northern Trust | 0.97% |
| 9 | Charles Schwab | 0.91% |
| 10 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.89% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.43% | 13F |
| Vanguard Group | 7.38% | 13F |
| State Street | 6.91% | 13F |
| S | 5.28% | 13G |
| Dimensional Fund Advisors | 2.32% | 13F |
| Geode Capital | 2.13% | 13F |
| Renaissance Technologies | 1.60% | 13F |
| Morgan Stanley | 1.56% | 13F |
| Northern Trust | 1.21% | 13F |
| T. Rowe Price | 1.03% | 13F |
Percentages above are of 118,029,526 shares outstanding, as reported by CATALYST PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CATALYST PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At CATALYST PHARMACEUTICALS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held August 22, 2023 and May 21, 2024), 333 asset managers reported how they voted in their SEC Form N-PX filings, covering 7,408 separate fund positions. Their filings are grouped here into 24 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held May 21, 2024 — To approve, on an advisory basis, the 2023 compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CATALYST PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.
CATALYST PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.